Safety and efficacy of ruxolitinib combined with prednisone, thalidomide and danazol therapy in patients with myelofibrosis: A retrospective cohort study
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Danazol (Primary) ; Prednisone (Primary) ; Ruxolitinib (Primary) ; Thalidomide (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions; Therapeutic Use
- 21 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association